The expression vector includes: the nucleic acids coding for the polypeptides forming a polypeptide complex having an enzyme activity allowing acetoacetyl-CoA to be converted to acetoacetate; optionally, at least one nucleic acid coding for a polypeptide having an enzyme activity allowing acetoacetate to be converted to acetone; and at least one nucleic acid coding for a polypeptide having an enzyme activity allowing acetone to be converted to isopropanol; the expression of the nucleic acids being controlled by a single constitutive promoter located upstream of the abovementioned nucleic acids.
1. Expression vector comprising:
a nucleic acid represented by the sequence SEQ ID NO: 1, or a nucleic acid having a sequence identity of at least 85%, particularly 90%, in particular 95% with the sequence SEQ ID NO: 1, coding for subunit A of the acetoacetyl-CoA transferase of a nucleic acid represented by the sequence SEQ ID NO: 2 or a nucleic acid having a sequence identity of at least 85%, particularly 90%, in particular 95% with the sequence SEQ ID NO: 2, coding for subunit B of the acetoacetyl-CoA transferase of optionally a nucleic acid represented by the sequence SEQ ID NO: 4 or a nucleic acid having a sequence identity of at least 85%, particularly 90%, in particular 95% with the sequence SEQ ID NO: 4, coding for the acetoacetate decarboxylase of a nucleic acid represented by the sequence SEQ ID NO: 3 or a nucleic acid having a sequence identity of at least 85%, particularly 90%, in particular 95% with the sequence SEQ ID NO: 3, coding for the secondary alcohol dehydrogenase of the expression of said nucleic acids being controlled by a single constitutive promoter located upstream of the abovementioned nucleic acids, said promoter being selected from the promoter represented by the sequence SEQ ID NO: 5 (thl promoter) and the promoter represented by the sequence SEQ ID NO: 6. 2. Expression vector according to a nucleic acid represented by the sequence SEQ ID NO: 1, a nucleic acid represented by the sequence SEQ ID NO: 2, a nucleic acid represented by the sequence SEQ ID NO: 3, a nucleic acid represented by the sequence SEQ ID NO: 4, and a promoter represented by the sequence SEQ ID NO: 5. 3. Expression vector according to a nucleic acid represented by the sequence SEQ ID NO: 1, a nucleic acid represented by the sequence SEQ ID NO: 2, a nucleic acid represented by the sequence SEQ ID NO: 3, and a promoter represented by the sequence SEQ ID NO: 5. 4. Microorganism comprising an expression vector according to 5. Microorganism according to 6. Microorganism according to 7. Microorganism according to 8. Microorganism according to 9. Method for the production of isopropanol, and/or of D and L 2,3-butanediol, characterized in that said method comprises:
cultivating a microorganism according to recovering the isopropanol, and/or D and L 2,3-butanediol, from the culture medium.
The present invention relates to a method for the production of isopropanol by improved recombinant strains. Isopropanol, also called 2-propanol, or isopropyl alcohol, is mainly used as a solvent for preparing inks and surfactants. Its other applications relate to the antiseptic and solvent properties of carboxymethylcellulose (CMC). Isopropanol is also used in the production of bases for cosmetics, as a solvent for pesticides or as a source of material in organic synthesis. As an indication, it may be mentioned that the production of isopropanol reached 45 million tonnes in the USA in 1990 (Papa A, 2005). Nowadays, isopropanol is produced by an essentially chemical method consisting of hydration of propylene by a direct or indirect route. The indirect route uses two steps. In the first step, a mixture of mono- and di-isopropyl sulphuric esters is produced, which is hydrolysed to isopropanol in a second step. The direct route uses the hydration of propylene at high pressure and low temperature on a “fixed-bed” acid catalyst (Logsdon J. E. and Loke R. A., 2001). From 1942 to 1958, isopropanol was produced in Taiwan by fermentation (Rogers et al. 2006). The substrates for the fermentation were sweet potato, cassava, and wheat starch, whereas the microorganism was a wild-type strain. Nowadays, this method for the production of isopropanol is no longer used industrially. In fact, the low yields obtained with wild-type strains (between 2 and 3 g/L of isopropanol for For ecological and economic reasons, research into the production of isopropanol by microbiological fermentation has experienced renewed interest in recent years. Isopropanol-producing fermentation is known as IBE fermentation. It differs from another solvent-producing fermentation, ABE fermentation, in that it produces isopropanol, solely or primarily, at the expense of acetone. The solvent-producing strains belong to the genus The biosynthetic pathway of isopropanol in (i) two molecules of acetyl-CoA are condensed to one molecule of acetoacetyl-CoA by acetyl-CoA transferase (EC 2.3.1.9), also called thiolase (Thl); (ii) the CoA of acetylCoA is transferred to the acetate or to the butyrate by acetoacetyl-CoA transferase (Ca_CtfAB) (EC 2.8.3.9) to give the acetoacetate; (iii) the acetoacetate is then converted to acetone and CO2 by acetate decarboxylase (Ca_Adc) (EC 4.1.1.4); (iv) finally, the acetone is converted to isopropanol by secondary alcohol dehydrogenase (Cb_s-Adh) (EC 1.1.1.2). Comparison of the enzyme activities in The gene coding for Cb_s-Adh has been sequenced (Petretz et al. 1997). The structure of the enzyme was determined by X-ray analysis. Cb_s-Adh is a homotetrameric zinc enzyme having four polypeptide chains of 351 amino acids. Each monomer is constituted by two domains. The first domain (residues 154-294) allows binding of the cofactor whereas the second domain incorporates the catalytic domain (residues 1-153 and 295-351) (Korkhin et al. 1998; Goihberg et al. 2010). Cb_s-Adh is similar to its homologue originating from the thermophilic bacterium The maximum capacity for producing isopropanol is relatively low (2 to 3 g/L) with the wild-type strains of International application WO 11/037414 describes another method capable of producing isopropanol. This method consists of using microorganisms of the genus Consequently, there is still a need to develop a method for the production of isopropanol with a better productivity and a better yield. The objective of the present invention is to rectify the drawbacks of the prior art and to propose a method for the production of isopropanol by fermentation having a better productivity and a better yield. The inventors have discovered that it is possible, advantageously, to produce isopropanol using recombinant microorganisms into which vectors have been introduced comprising the genes coding for the enzymes of the metabolic pathway leading from acetoacetyl-CoA to acetone, namely CoA transferase subunits A and B and acetoacetate decarboxylase, as well as the gene coding for a secondary alcohol dehydrogenase of The first objective of the present invention is to provide an expression vector comprising:
By “expression vector” is meant an exogenous DNA molecule of circular shape, which is capable of autonomous and independent replication of the chromosomal DNA of the host cells, allowing transcription and translation of the genes contained in said DNA molecule by means of the host cells. In the present invention, the term “vector” and the term “plasmid” are interchangeable. By “promoter” is meant a region of DNA where RNA polymerase binds and orients this enzyme towards the site where transcription of the gene will begin. The promoters can be constitutive or inducible. By “constitutive promoter” is meant an unregulated promoter allowing continuous transcription of the associated gene. In contrast to a constitutive promoter, an inducible promoter allows transcription of the associated gene in response to the presence of a particular compound, for example the presence of IPTG, or to a defined external condition, for example a high temperature. By “a promoter . . . located upstream of the . . . nucleic acids” is meant a promoter located before the 5′ ends of the nucleic acids. The conversion of acetoacetyl-CoA to acetoacetate is carried out by acetoacetyl-CoA transferase. In most microorganisms, this enzyme is formed by two subunits encoded by two different genes. Thus, the acetoacetyl-CoA transferase of In a particular embodiment, the present invention relates to a vector comprising:
Expression of the gene of the secondary alcohol dehydrogenase of In a more particular embodiment, the present invention relates to a vector comprising:
The nucleic acid represented by the sequence SEQ ID NO: 1 codes for subunit A of the acetoacetyl-CoA transferase of The nucleic acid represented by the sequence SEQ ID NO: 2 codes for subunit B of the acetoacetyl-CoA transferase of The nucleic acid represented by the sequence SEQ ID NO: 3 codes for the secondary alcohol dehydrogenase of The nucleic acid represented by the sequence SEQ ID NO: 4 codes for the acetoacetate decarboxylase of The percentage identity between two peptide sequences or between two nucleic acid sequences can be calculated from the following formula: The combinations of the abovementioned nucleic acids (or genes) form the “ipa” operons. Expression of the genes of the abovementioned ipa operons is controlled by a single constitutive promoter located upstream of the abovementioned nucleic acids (or genes). A constitutive promoter, which only controls the expression of the ipa operons, allows constitutive expression of the latter, which allows a recombinant strain containing one of the vectors of the invention to produce isopropanol as from the first hours of fermentation. Owing to the early expression of the genes that lead to the production of isopropanol, the mechanism of solventogenesis is triggered earlier in a recombinant strain containing a vector according to the invention than in a wild-type strain. Consequently, two fermentation phases, namely, acidogenesis and solventogenesis, take place at the same time in a recombinant strain containing a vector according to the invention, which makes it possible to reduce the fermentation time by at least 20 hours. The constitutive promoter used in the construction of the vector of the present invention can be the promoter of the gene coding for the thiolase of In a particular embodiment, the expression vector of the present invention comprising:
In a particular embodiment, the vector of the present invention comprises:
This vector designated pFC007 contains, in the order from the 5′ end to the 3′ end, the gene coding for the secondary alcohol dehydrogenase (Cb_s-adh) of In another particular embodiment, the vector of the present invention comprises:
This vector designated pFC006 contains the gene coding for the secondary alcohol dehydrogenase (Cb_s-adh) of The expression vectors according to the present invention can further comprise any other element necessary for the transcription and translation of the aforementioned enzymes, such as an RBS (ribosome binding site) region, one or more selection genes. An RBS region allows binding of the ribosome to the messenger RNA molecule before the start codon of a gene. The sequence of RBS region used in the vectors of the present invention can be any sequence of RBS region of prokaryotic origin known to a person skilled in the art. The presence of a selection gene in a vector according to the invention makes it possible to select the microorganisms that have been transformed successfully. A selection gene in a vector allows the microorganisms comprising said gene to survive under certain particular conditions, or can lead to the presence of a molecule that can be easily identified. The selection gene used in the vectors of the present invention can be any selection genes known to a person skilled in the art, in particular a gene endowing the microorganisms with antibiotic resistance, such as the gene Amp, or ErmB. The expression vectors also comprise replication origins, which allow initiation of the replication of said vectors in the host microorganisms. The replication origin used in the vectors of the present invention can be any replication origin known to a person skilled in the art. The present invention also aims to provide a recombinant microorganism for producing isopropanol with a better productivity and a better yield. Said microorganism comprises an expression vector as described in the present invention. In particular, said microorganism comprises a vector comprising:
In an advantageous embodiment, said microorganism comprises the vector pFC007. In another advantageous embodiment, said microorganism comprises the vector pFC006. Said microorganism of the present invention can be selected from bacteria of the genus In a particular embodiment, the microorganism according to the invention is In a more particular embodiment, the microorganism according to the invention is the strain In a particularly advantageous embodiment, the invention relates to a recombinant strain of In another particularly advantageous embodiment, the invention relates to a recombinant strain of For the two recombinant strains (ATCC 824(pFC007) and ATCC 824(pFC006)), production of isopropanol can be detected as from the first 10 hours of culture, whereas no trace of solvents (ABE) is detectable in the wild-type strain of Another aim of the present invention is to provide a method for the production of isopropanol, and/or of D and L 2,3-butanediol, with a better productivity and a better yield. Said method comprises at least the following steps:
The culture media are known to a person skilled in the art. The carbon source can be starch, glucose, xylose, lignocellulosic hydrolysates. The nitrogen source can be ammonia, yeast extract, peptone, urea. The culture conditions for microorganisms of the genus The recovery of the isopropanol, and/or of D and L 2,3-butanediol, from the culture medium is performed by distillation (Mujiburohman et al. 2006). The examples and figures presented below illustrate the present invention in more detail. However, the scope of the present invention must in no case be limited to these examples or figures. The kits used in the operations of molecular biology (construction of the plasmid vectors) are presented in Table 1. The strains used in the examples of the present invention are:
The fermentation samples (2 mL) are centrifuged for 5 minutes at 20,000 g and the supernatants are used for assaying the fermentation metabolites (glucose, acetic and butyric acid, 2,3-butanediol, acetone, ethanol, isopropanol and butanol). For each sample, an equivolume of an acid solution (0.5 mM H2SO4) containing the internal standard (30 mM of 4-methylvaleric acid) is added, the mixture is then homogenized and filtered (0.2 μm, Whatman). 10 μL of sample is then injected and analyzed in a Shodex lonpack KC-811 column (RP). The assayed compounds are detected at column outlet by two detectors: a refractometer (Waters 2487) and a spectrophotometer (Waters 2487) measuring the absorbance at 210 nm. The eluent used is a 3 mM solution of sulphuric acid, the flow rate of the eluent is 1 mL/min and the column temperature is fixed at 85° C. The genetic structures of the vectors used or constructed in the examples of the present invention are summarized in Table 2 below. Construction of the vector pFC007 from the plasmid pMTL500E ( Step 1: Construction of the Vector pFC002 The vector pFC002 is constructed from the plasmid pMTL500E. The latter is digested with the restriction enzymes sphI and xhoI on the lacZ gene. The digestion product is then dephosphorylated. The restriction sites sphI and apaI are added respectively at 5′ and 3′ of the DNA sequence of the promoter Pthl, by the PCR technique using the primers Ca_thlp-for and Ca_thlp_rev derived from the genomic DNA of The PCR product thus obtained is digested with the restriction enzymes apaI and xhoI. The digested plasmid, the digested promoter and the digested gene originating from the PCR are ligated together to give a vector called pFC002 ( Step 2: Construction of the Vector pFC006 from the Plasmid pFC002 The vector pFC002 is digested with the restriction enzymes xhoI and XbaI. The genes coding for Ca_CtfAB are amplified together starting from the genomic DNA of Step 3: Construction of the Vector pFC007 from the Plasmid pFC006 The vector pFC006 is digested with the restriction enzymes xhoI and XbaI. The gene coding for Ca_Adc is amplified from the genomic DNA of The added restriction sites (sphI, apaI, xhoI, SalI, xbaI and speI) are underlined. The ribosome binding sites are shown in bold. The prefix “Ca” means that the primer is used on the genomic DNA of Using similar methods, the gene coding for Ca_Adc can be inserted into the vector pFC002 to obtain the vector pFC005. According to similar methods, the genes coding for Ca_CtfAB can then be inserted into the vector pFC005 to obtain the vector pFC008. Transformation of The vectors pFC002, pFC006 and pFC007 are first methylated respectively by cotransformation with the plasmid pAN1 in the The wild-type strain of In order to confirm the presence of one of the vectors described above in the strain Fermentations were carried out in a culture medium described by Gapes et al. (GAPES et al., 1996), containing 90 g/L of glucose with wild-type strains, Approximately 50 hours of fermentation are needed to reach 95% of the final production of solvents. The presence of solvent (butanol) can only be detected 11 hours after inoculation. Neither isopropanol nor 2,3-butanediol is produced by the wild-type strain Fermentation of Glucose by the Recombinant Strain Fermentation of Glucose by the Recombinant Strain Like the recombinant strain ATCC 824(pFC002), the recombinant strain ATCC 824(pFC006) produces isopropanol and 2,3-butanediol instead of acetone and acetoin. However, in contrast to the profile of production for the recombinant strain ATCC 824(pFC002), the recombinant strain ATCC 824(pFC006) can reach a high level of production of solvents over a shorter period of time. The time necessary to reach 95% of the final production of solvent for this strain is approximately 30 hours. The consumption of butyric acid is more effective than that of the wild-type strain or of the recombinant strain ATCC 824(pFC002), but remains incomplete. The production of solvents in this strain begins earlier than for the wild-type strain or for the recombinant strain ATCC 824(pFC002). The production of isopropanol can be detected as from the first 10 hours of culture of the strain ATCC 824(pFC006), whereas traces of solvents are not yet detectable in the wild-type strain or in the strain ATCC 824(pFC002). Moreover, the incorporation of acetate and of butyrate in the strain ATCC 824(pFC006) are both improved relative to those in the wild-type strain, which makes it possible to have an isopropanol yield better than the acetone yield of the wild-type strain. For the strain ATCC 824(pFC007), the respective titres of isopropanol, butanol and ethanol are 7.3 g/L, 11.8 g/L and 1.37 g/L, in other words 28%, 31% and 6% higher than those of the wild-type strain. The productivity is increased from 0.41 g/L·h for a wild-type strain to 0.69 g/L·h for the strain ATCC 824(pFC007). The strain ATCC 824(pFC006) produces twice as much 2,3-butanediol than the strain ATCC 824(pFC002), and this increase in production of 2,3-butanediol may be due to an overall improvement in metabolic flux. It is found that the improvement in the incorporation of acids allows the strain ATCC 824(pFC006) to produce less acids and to increase its production of solvents. However, despite overexpression of the enzyme Ca_CtfAB, the final production of acetate is higher in the strain ATCC 824(pFC006) than in the wild-type strain, which may be due to increased production of acids as a result of an overall improvement in metabolic flux. Fermentation of Glucose by the Recombinant Strain The strain ATCC 824(pFC007) has a fermentation profile similar to that of the strain ATCC 824(pFC006). The time to reach 95% of the final production of solvents is less than 30 hours. Acidogenesis begins normally. The production of solvents in the strain ATCC 824(pFC007) begins during the exponential phase and earlier than in the wild-type strain. The presence of isopropanol can be detected in the culture medium of the strain ATCC 824(pFC007), only 4 hours after inoculation, whereas acetone is not yet detectable in the culture medium of a wild-type strain. Moreover, the incorporation of acetate and of butyrate in the strain ATCC 824(pFC007) are both improved relative to those in the strain ATCC 824(pFC006), which makes it possible to have a better isopropanol yield relative to that of the strain ATCC 824(pFC006), or of other strains described previously. In the strain ATCC 824(pFC007), the respective titres of isopropanol, butanol and ethanol are 8.4 g/L, 13.0 g/L and 1.71 g/L, in other words 46%, 44% and 36% higher than those of the wild-type strain. Productivity is increased from 0.41 g/L·h for a wild-type strain to 0.81 g/L·h for the strain ATCC 824(pFC007). The production of 2,3-butanediol, of the strain ATCC 824(pFC007), is similar to that of the strain ATCC 824(pFC006). As for the strain ATCC 824(pFC006), this increase in the production of 2,3-butanediol may be due to an overall improvement in metabolic flux. Fermentation of Glucose by the Wild-Type Strain The wild-type strain After 34 hours of fermentation, the wild-type strain of As expected, the wild-type strain The recombinant strains ATCC 824(pFC006) and ATCC 824(pFC007) both exhibit better solvents productivity than the wild-type strain BIBLIOGRAPHICAL RESEARCH
DESCRIPTION OF THE INVENTION
the expression of said nucleic acids being controlled by a single constitutive promoter located upstream of the abovementioned nucleic acids.
the expression of said nucleic acids being controlled by a single constitutive promoter located upstream of the abovementioned nucleic acids, said promoter being selected from the promoter represented by the sequence SEQ ID NO: 5 (thl promoter) and the promoter represented by the sequence SEQ ID NO: 6.
the expression of said nucleic acids being controlled by a single constitutive promoter located upstream of the abovementioned nucleic acids, said promoter being selected from the promoter represented by the sequence SEQ ID NO: 5 (thl promoter) and the promoter represented by the sequence SEQ ID NO: 6.
FIGURES
EXAMPLES
Materials and methods
Equipment and Materials
Kits and materials used in the operations of molecular biology Name of the kit Use Supplier Restriction enzymes: apaI, speI, Enzymatic digestion of plasmid DNAs New England sphI, xbaI and xhoI Biolabs (NEB) High Fidelity PCR Master Mix ™ PCR amplification Roche DreamTaq ™ PCR amplification Fermentas Oligonucleotides (Table 3) Primers for the PCR reactions, created by BaseClear the inventors Alkaline phosphatase dephosphorylation of the 5′ ends of the New England linearized vectors preventing self-ligation Biolabs T4 DNA ligase ligation of DNA fragment New England Biolabs (NEB) GenJET ™ plasmid miniprep Extraction of plasmid DNA from cultures of Fermentas GenElute ™ Bacterial Genomic Extraction of genomic DNA from bacteria Sigma-Aldrich DNA (Gram-positive and Gram-negative) Z-Competent ™ Production of chemocompetent bacteria Zymo Research transformation XL1 blue and Assaying of Solvents (Acetone, Acetoin, Isopropanol, Butanol, Butanediol) and Carboxylic Acids (Butyric and Acetic Acids)
Construction of the Vectors
Genetic structures of the vectors selective Plasmid marker Description Reference pMTL500E ermB/ampR Empty vector Oultram et al., 1988 pFC002 ermB/ampR Ca_thlp [Cb_s-adh] This document pFC005 ermB/ampR Ca_thlp [Cb_s-adh; This document Ca_adc] pFC006 ermB/ampR Ca_thlp [Cb_s-adh; This document Ca_ctfAB] pFC007 ermB/ampR Ca_thlp [Cb_s-adh; This document Ca_adc; Ca_ctfAB] pAN2 ttc (Mermelstein, 1993; Heap, 2009) ermB: erythromycin resistance gene; ampR: ampicillin resistance gene; ttc: tetracycline resistance gene; Ca: this prefix indicates that the gene originates from Cb: this prefix indicates that the gene originates from Ca_thl: thiolase gene; Cb_s-adh: gene of the secondary dehydrogenase of Ca_adc: gene of the acetate decarboxylase of Ca_CtfAB: gene of the CoA transferase of Primers used for constructing the ipa operons Primers Sequence (5′-3′) Ca_thlp-for GCATGCGAATTTAGAATGAAGTTTCTTATGCA (SEQ ID NO: 7) Ca_thlp_rev GGGCCCCCATAGTTTATCCCTAATTTATACG (SEQ ID NO: 8) Cb_s-adh-for GGGCCCTTAGACTATTAAAGGAATATTTTTAAGG (SEQ ID NO: 9) Cb_s-adh-rev TTTTCTCGAGGTATAATCCTCCATGATCTATTATG (SEQ ID NO: 10) Ca_ctf A &B CAACTACTCGAGATAATTTTTCTAGAGAATTTAAA for AGGAGGGATTAAAATG (SEQ ID NO: 11) Ca_ctf A &B AATGGTACTAGTTATTTTTTGTCGACTGTTTCATA rev GTATTTCTTTCTAAACAGCC (SEQ ID NO: 12) Ca_adc for AAACAACTCGAGTTATAATCTAGATATAAATAAATA GGACTAGAGGCG (SEQ ID NO: 13) Ca_adc rev AAAAATACTAGTTACCATTTAAGTCGACTCTTATTT TTATTACTTAAG (SEQ ID NO: 14)
The prefix “Cb” means that the primer is used on the genomic DNA of Genetic Characterization of the Recombinant Strains
Identification of the vectors pFC005, pFC006 or pFC007 in 824 by PCR Size of PCR fragments expected [kbp] for the primer pairs: Cb_thlp for Cb_s-adh for Cb_s-adh for Ca_adc for Ca_ctfAB for PCR mix Cb_s-adh rev Ca_adc rev Ca_ctfAB rev Ca_ctfAB rev Ca_adc rev pFC002 1.4 pFC005 1.4 2.0 No No No pFC006 1.4 No 2.5 No No pFC007 1.4 2.0 3.4 2.3 No pFC008 1.4 3.4 2.5 No 2.3 Fermentation of the Recombinant Strains
Final performances on glucose by wild-type and recombinant strains of NRRL B 593 and of NRRL B 593 ATCC 824 ATCC 824 ATCC 824 ATCC 824 Characteristic wild-type wild-type (pFC002) (pFC006) (pFC007) Glucose consumed [g/L] 34.30 61.99 54.82 69.26 67.79 Lactic acid [g/L] 0.55 0.00 −0.16 0.17 0.19 Acetic acid [g/L] 0.83 2.86 4.61 3.24 1.61 Acetoin [g/L] 0.00 0.59 0.10 0.06 0.05 2,3-Butanediol [g/L] 0.00 0.08 0.48 0.91 0.88 Butyric acid [g/L] 0.21 2.02 2.51 1.08 1.06 Acetone [g/L] 0.17 5.70 0.05 0.35 0.09 Ethanol [g/L] 0.12 1.26 0.31 1.34 1.71 Isopropanol [g/L] 4.47 0.10 4.25 7.27 8.37 Butanol [g/L] 8.08 8.98 8.22 11.80 12.95 IBE or ABE [g/L] 12.83 16.04 12.82 20.76 23.12 Fermentation time [h]* 33.5 49.5 >45 29.9 28.0 Maximum productivity for 0.41 0.41 0.33 0.69 0.81 IBE or ABE [g/L · h] Yield of IBE or ABE [g/g 0.37 0.26 0.24 0.30 0.34 substrate] Selectivity for isopropanol 0.35 0.01 0.33 0.35 0.36 [g/g solvents] Selectivity for acetone 0.01 0.36 <0.01 0.02 0.00 [g/g solvents] *time necessary to reach 95% of the final production of solvent.
Fermentation of Glucose by the Wild-Type Strain CONCLUSION
REFERENCES